Tuberc Respir Dis.  2019 Apr;82(2):91-93. 10.4046/trd.2018.0032.

The Development of the Korean Lung Cancer Registry (KALC-R)

• Kim YC
• Won YJ

• KMID: 2453978
• DOI: http://doi.org/10.4046/trd.2018.0032

Abstract

Lung cancer is the most commonly diagnosed cancer and the leading cause of cancer-related deaths worldwide. Globally, there were an estimated 1.8 million new cases and 1.59 million deaths in 2012. In Korea, the incidence of lung cancer is increasing and 24,267 (47.6/100,000) patients with lung cancer were registered at the Korea Central Cancer Registry in 2015. Previous nationwide surveys of lung cancer were performed in 1998 by the Korean Academy of Tuberculosis and Respiratory Diseases and in 2007 by the Korean Association for Lung Cancer (KALC), but the studies faced difficulties in maintaining lung cancer registry because of limitations regarding the Private Information Protection Act. To produce unbiased and reliable epidemiological data, the KALC and Korean Central Cancer Registry developed a detailed lung cancer registry (KALC-R) data structure. Following a pilot survey of 489 lung cancer cases in 2013, about 10% of the sampled lung cancer cases from the Korean Central Cancer Registry are surveyed each year. With the analysis of detailed data from the KALC-R, an important epidemiological background for scientific research or policy development is expected to be generated.

Keyword

Lung Neoplasms; Registries; Smokers

MeSH Terms

Computer Security
Humans
Incidence
Korea
Lung Neoplasms*
Lung*
Policy Making
Registries
Tuberculosis

Figure

• 

  Figure 1 Comparison of the proportion of adenocarcinoma, female patients, and lung cancer patients who have never smoked, as reviewed between the national surveys of 1997, 2005, and 2013.

Reference

1. Ferlay J, Soerjomataram I, Dikshit R, Eser S, Mathersz C, Rebelo M, et al. GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet]. Lyon: International Agency for Research on Cancer;2013. cited 2018 Jul 1. Available from: http://globocan.iarc.fr.

2. Lee C, Kang KH, Koh Y, Chang J, Chung HS, Park SK, et al. Characteristics of lung cancer in Korea, 1997. Lung Cancer. 2000; 30:15–22.

3. In KH, Kwon YS, Oh IJ, Kim KS, Jung MH, Lee KH, et al. Lung cancer patients who are asymptomatic at diagnosis show favorable prognosis: a korean Lung Cancer Registry Study. Lung Cancer. 2009; 64:232–237.

4. Brierley J, Gospodarowicz MK, Wittekind C. TNM classification of malignant tumours. 8th ed. Chichester: John Wiley & Sons, Inc.;2017.

5. Kim HC, Jung CY, Cho DG, Jeon JH, Lee JE, Ahn JS, et al. Clinical characteristics and prognostic factors of lung cancer in Korea: a pilot study of data from the Korean nationwide lung cancer registry. Tuberc Respir Dis. 2018; 06. 19. DOI: 10.4046/trd.2017.0128. [Epub].

6. Yano T, Miura N, Takenaka T, Haro A, Okazaki H, Ohba T, et al. Never-smoking nonsmall cell lung cancer as a separate entity: clinicopathologic features and survival. Cancer. 2008; 113:1012–1018.

7. Kang H, Park CW, Kim W, Song SY, Na KJ, Jeong JU, et al. Never-smoker lung cancer is increasing. J Lung Cancer. 2012; 11:89–93.

8. Dias M, Linhas R, Campainha S, Conde S, Barroso A. Lung cancer in never-smokers: what are the differences? Acta Oncol. 2017; 56:931–935.

9. Pelosof L, Ahn C, Gao A, Horn L, Madrigales A, Cox J, et al. Proportion of never-smoker non-small cell lung cancer patients at three diverse institutions. J Natl Cancer Inst. 2017; 01. 28. DOI: 10.1093/jnci/djw295. [Epub].